Dialysis Rate in Taiwan is the Highest Worldwide! The Phase III Trial of the EPO Injection Developed by UBI Pharma has been Completed, the Company Plans to Submit an Application for Drug Licensing to the TFDA 2022 年 1 月 20 日 Read More
Successful Unblinding of the Phase III Clinical Trial of Erythropoietin Conducted by UBI Pharma, a Subsidiary of United Biomedical 2021 年 6 月 11 日 Read More
San Miguel County orders residents to shelter in place before countywide coronavirus testing 2020 年 3 月 18 日 Read More
The Unique Long-acting Technology Platform Developed by UBI Pharma Has Been Granted a Patent by the United States and Canada 2019 年 10 月 2 日 Read More
TFDA Approves the Phase I Clinical Trial of the New Drug UB-852 Developed by UBI Pharma 2019 年 6 月 10 日 Read More
TFDA Approves the Phase I Clinical Trial of the New Targeted Anticancer Drug UB-941 Developed by UBI Pharma 2019 年 3 月 5 日 Read More
